Periodontal ligament mesenchymal stem cells (PDLMSCs) are an important alternative source of adult stem cells and may be applied for periodontal tissue regeneration, neuroregenerative medicine, and heart valve tissue engineering. However, little is known about the impact of bacterial toxins on the biological properties of PDLSMSCs, including self-renewal, differentiation, and synthesis of extracellular matrix.Objective: This study investigated whether proliferation, expression of pro-inflammatory cytokines, and osteogenic differentiation of CD105-enriched PDL progenitor cell populations (PDL-CD105+ cells) would be affected by exposure to bacterial lipopolysaccharide fromEscherichia coli(EcLPS).Material and Methods : Toll-like receptor 4 (TLR4) expression was assessed in PDL-CD105+ cells by the immunostaining technique and confirmed using Western blotting assay. Afterwards, these cells were exposed to EcLPS, and the following assays were carried out: (i) cell viability using MTS; (ii) expression of the interleukin-1 beta (IL-1β), interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor alpha (TNF-α) genes; (iii) osteoblast differentiation assessed by mineralization in vitro, and by mRNA levels of run-related transcription factor-2 (RUNX2), alkaline phosphatase (ALP) and osteocalcin (OCN) determined by quantitative PCR.Results : PDL-CD105+ cells were identified as positive for TLR4. EcLPS did not affect cell viability, but induced a significant increase of transcripts for IL-6 and IL-8. Under osteogenic condition, PDL-CD105+ cells exposed to EcLPS presented an increase of mineralized matrix deposition and higher RUNX2 and ALP mRNA levels when compared to the control group.Conclusions : These results provide evidence that CD105-enriched PDL progenitor cells are able to adapt to continuous Escherichia coli endotoxin challenge, leading to an upregulation of osteogenic activities.

O objetivo do presente estudo foi comparar a utilização pré-emptiva de medicamento inibidor da COX-2 (cicloxigenase-2) com uma droga antinflamatória esteroidal amplamente utilizada, para o controle da dor e edema após cirurgia periodontal para aumento de coroa. Trinta pacientes que necessitavam de cirurgia periodontal foram aleatoriamente designados a receber uma das seguintes medicações: inibidor seletivo da COX-2 ou a droga antinflamatória esteroidal, 60 min antes do procedimento cirúrgico. Para avaliar a ansiedade do paciente, a escala de ansiedade ao tratamento dental de Corah foi aplicada antes da cirurgia. Com a utilização de escala analógica visual a extensão de dor/desconforto durante o período trans-cirúrgico e imediatamente após a cirurgia foi mensurada. Adicionalmente, a intensidade de dor/desconforto e edema foram avaliados no periodo pós-operatório tardio 4, 8, 12 e 24 h após o procedimento cirúrgico. Com relação à ansiedade, não foi observada diferença estatística entre os grupos (p>0,05). Com relação à extensão de dor/desconforto durante os períodos trans-cirúrgico e pós operatório imediato e tardio, os dados não demonstraram diferenças entre o grupo que recebeu o inibidor seletivo da COX-2 e o aintinflamatório esteroidal (p>0,05). A avaliação do edema, intragrupo, não revelou diferença estatística durante as primeiras 24 h em nenhum dos grupos estudados (p>0,05). Em conclusão, ambas as drogas antiinflamatórias utilizadas apresentaram um potencial similar no controle da dor e edema após cirurgia periodontal.

The aim of the present study was to compare the pre-emptive use of a cyclooxygenase-2 (COX-2) inhibitor with a well established steroidal anti-inflammatory drug for pain and edema relief following periodontal surgery for crown lengthening. Thirty patients requiring periodontal surgery were randomly assigned to receive one of the following medications: selective COX-2 inhibitor or steroidal anti-inflammatory drug, 60 min before the surgical procedure. To examine patient anxiety, a Corah's dental anxiety scale was applied before surgery. Using a visual analog scale, the extent of pain/discomfort during the trans-operative period and immediately after the surgery was measured. Additionally, intensity of pain/discomfort and edema were examined 4, 8, 12 and 24 h postoperatively. With regard to anxiety, no statistical differences between the groups were observed (p>0.05). With respect to the extent of pain/discomfort during the trans-operative, immediate and late postoperative period, data demonstrated no significant differences (p>0.05) between the COX-2 inhibitor and steroidal groups. With regard to edema, intragroup analysis did not reveal any statistically significant difference (p>0.05) during the 24 h following surgery in either group. In conclusion, both anti-inflammatory drugs presented a similar potential for pain and edema relief following periodontal surgery.

OBJECTIVE: This study was designed to evaluate, histomorphometrically, the association of platelet-rich plasma (PRP) and bioactive glass (BG) in the treatment of periodontal intrabony defects. MATERIAL AND METHODS: Nine mongrel dogs were included in the study. Three-wall intrabony defects were surgically created at the mesial and distal aspect of first mandibular molar and exposed to plaque accumulation for 1 month. The defects were randomly assigned to the groups: control, BG, PRP, PRP+BG. Dogs were sacrificed 90 days after the surgeries. The histometric parameters evaluated were: length of sulcular and junctional epithelium, connective tissue adaptation, new cementum, new bone, defect extension and area of new bone filling the defect. RESULTS: A superior area of new bone was observed in PRP+BG and BG (13.80±2.32 mm² and 15.63±2.64 mm², respectively) when compared to the other groups (8.19±1.46 mm² and 8.81±1.47 mm² for control and PRP, respectively). No statistically significant differences were observed in the remaining parameters. CONCLUSIONS: Within the limits of this study, it may be concluded that PRP failed to provide statistically significant improvements in the histometric parameters.

O objetivo deste estudo foi avaliar o defeito na superfície radicular produzido por curetas manuais e instrumento ultra-sônico em diferentes potências. Quarenta superfícies radiculares foram divididas de acordo com o tratamento em 4 grupos: a) Curetas Gracey; b) Instrumento ultra-sônico a 10%; c) Instrumento ultra-sônico a 50%; d) Instrumento ultra-sônico a 100%. Cada amostra recebeu 15 movimentos de raspagem e foram divididas ao meio para avaliar: (1) a profundidade do defeito produzido pela instrumentação e (2) a área de contato do instrumento com a superfície. Todas as superfícies foram então avaliadas com o uso de Microscopia Eletrônica de Varredura. Para a análise estatística foi utilizado o teste Tukey/ANOVA. Os resultados (média ± DP) encontrados para a área de contato foram significantemente maiores para a instrumentação manual (2092,9 ± 482,0) que para os instrumentos ultra-sônicos, independentemente da potência utilizada (606,8 ± 283,0; 858,6 ± 422,5; 1212,0 ± 366,7, respectivamente). Os valores para a profundidade do defeito demonstraram numericamente, mas não estatisticamente, diferenças entre a instrumentação manual (66,1 ± 34,0) e ultra-sônica em 10%, 50% ou 100% de potência (52,4 ± 22,1; 72,0 ± 29,9; 77,7 ± 37,7, respectivamente). Os resultados encontrados demonstraram que a instrumentação ultra-sônica produziu defeitos com profundidade similar aos produzidos pela instrumentação manual, com um menor contato do instrumento, independente da potência utilizada.

The aim of this study was to evaluate the root surface defect produced by hand curettes and ultrasonic tips with different power settings. Forty root surfaces were divided into 4 groups according the treatment: Gracey curettes, ultrasonic scaler at 10% power, ultrasonic scaler at 50% power and ultrasonic scaler at 100% power. Each specimen was instrumented with 15 strokes and the and divided in the middle to evaluate: (1) the defect depth produced by the instrumentation and (2) contact area of the instrument tips, which was analyzed by scanning electron microscopy. ANOVA and Tukey's test were used for statistical analysis (a=0.05). The results (mean ± SD) of the contact area showed significantly greater defects (p<0.05) for the hand instrumented groups (2092.9 ± 482) compared to the ultrasonic groups (606.8 ± 283.0; 858.6 ± 422.5; 1212.0 ± 366.7, respectively), independently of the power setting. The values for the defect depth on root surface showed no statistically significant difference (p<0.05) between hand instrumentation (66.1 ± 34.0) and ultrasonic scaling at 10%, 50% or 100% power settings (52.4 ± 22.1; 72.0 ± 29.9; 77.7 ± 37.7, respectively). The findings of this study demonstrate that ultrasonic instrumentation produced a similar defect depth to that of hand instrumentation, with a smaller tip contact area, independently of the power setting used for scaling.

Neste estudo avaliou-se histometricamente a ação local da calcitonina de salmão em defeitos ósseos provocados cirurgicamente em fêmur de ratos. As avaliações foram feitas aos 7, 14 e 21 dias após o ato cirúrgico. Não se observou diferenças estatísticas aos 7 dias, entretanto no período de 14 dias houve diferenças com maior formação óssea no grupo tratado. No período de 21 dias, em ambos os grupos, não foi possível diferenciar o tecido ósseo neoformado e o adjacente. Os resultados demonstraram, que o efeito da calcitonina foi observado somente no início do processo de reparo dos defeitos ósseos criados cirurgicamente.

The purpose of the present study was to histometrically evaluate the effects of salmon calcitonin on the bone healing of surgically created bone defects in rats. The animals were sacrificed 7, 14 and 21 days after the surgical procedure. After the 7- and 21-day periods, differences between the experimental and control groups were not observed (P > 0.01). After the 14-day period, a larger amount of new bone was observed in the experimental group (P < 0.01). Thus, within the limits of the present study, it can be concluded that although salmon calcitonin positively participated in the initial phase of bone healing, it did not result in a larger amount of new bone at the end of the experimental period.